From Our Partners
Tuesday, June 28, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

B3 Solutions Selected for JPEO Chem-Bio Defense Omnibus Support

by Global Biodefense Staff
March 20, 2013

B3 Solutions, LLC. this week announced it has been awarded a prime position on the Acquisition Domain of the Omnibus Program Engineering and Technical Support contract supporting the development and fielding of chemical and biological defense materiel for the Department of Defense Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD).

The five-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract expands B3 Solutions’ presence at JPEO-CBD. Including B3 Solutions, there are 22 awardees in the Acquisition Domain. All awardees have the potential to receive the full value amount of the IDIQ contract if all options are exercised.

B3 Solutions will compete for JPEO-CBD task orders to provide acquisition, program management and relations management in CBD and national security communities, strategic planning, program analysis, life cycle management, international program analysis on foreign military sales, equipment expertise on the production and usage of CBD protective equipment, multimedia, graphics, technical writing support, and administrative support.

“We look forward to providing the critical expertise required to help develop chemical and biological defense solutions,” said William Almas, B3 Solutions CEO. “Nothing is more important than keeping our armed forces and civilians out of harm’s way.”

The JPEO-CBD is responsible for research, development and acquisition support of chemical, biological, radiological, and nuclear defense equipment and medical countermeasures for missions overseas and at home.

Source: B3 Solutions 

From Our Partners
Tags: AwardsJPEO-CBRND

Related Posts

Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC